Denosumab Injection (Xgeva) and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Denosumab Injection (Xgeva) and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Injection (Xgeva)-Insulin glargine, recombinant Subcutaneous
- Denosumab Injection (Xgeva)-Insulin glulisine
- Denosumab Injection (Xgeva)-Insulin Glulisine (Cartridges and Pens)
- Denosumab Injection (Xgeva)-Insulin Glulisine (Vials)
- Denosumab Injection (Xgeva)-Insulin glulisine Subcutaneous
- Denosumab Injection (Xgeva)-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Denosumab Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Denovo
- Insulin glargine and lixisenatide Subcutaneous-Dent-O-Kain/20
- Insulin glargine and lixisenatide Subcutaneous-Denti-Care Denti-Freeze Topical Anesthetic
- Insulin glargine and lixisenatide Subcutaneous-DentiPatch
- Insulin glargine and lixisenatide Subcutaneous-Deoxycholic acid